Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1996-9-9
|
pubmed:abstractText |
The purpose of this study was to determine the dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block. Seventy-five ASA I or II adults were given mivarcurium 0.15 mg x kg(-1) followed by an infusion (7 micrograms x kg(-1) x min(-1) during alfentanil-propofol-N2O-enflurane anaesthesia. Train-of-four stimulation (TOF) was applied to the ulnar nerve every 20 sec and the response of the adductor policis was recorded (Relaxograph NMT-100, Datex, Helsinki, Finland). Mivacurium infusion was modified at five-minute intervals in order to keep the height of the first twitch in TOF(T1) at 5% of its control value. At the end of surgery, edrophonium (0.0, 0.125, 0.25, 0.5, or 1.0 mg x kg(-1) combined glycopyrrolate (0.0, 0.0012, 0.0025, 0.005, or 0.01 mg x kg(-1) were administered by random allocation. Edrophonium doses of 0.25, 0.5 and 1.0 mg x kg(-1) were different from placebo with regard to time to attain a TOF ratio (fourth twitch in TOF/T1) = 0.7 (13.8 +/- 4.5, 11.1 +/- 3.5, 11.4 +/- 3.0 vs 19.7 +/- 4.7 min P< 0.05). Doses of 0.5 and 1.0 mg x kg(-1) permitted faster recovery time of T1 from 10 to 95% (T10-95) than did placebo (7.5 +/- 3.8, 8.9 +/- 3.5 vs 14.5 +/- 5.0 min P<0.05). Edrophonium 0.5 mg x kg(-1) was different from placebo with regard to recovery time of T1 from 25 to 75% (T25-75) (3.3 +/- 2.0 vs 6.7 +/- 2.0 min P<0.05). Only edrophonium 0.5 mg x kg(-1) provided faster recovery than placebo with regard to all three indices. It is concluded that edrophonium 0.5 + glycopyrrolate 0.005 mg x kg(-1) allow the fastest recovery from a mivacurium-induced block during enflurane-N2O anaesthesia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alfentanil,
http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Edrophonium,
http://linkedlifedata.com/resource/pubmed/chemical/Enflurane,
http://linkedlifedata.com/resource/pubmed/chemical/Isoquinolines,
http://linkedlifedata.com/resource/pubmed/chemical/Neuromuscular Nondepolarizing Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Nitrous Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/mivacurium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0832-610X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
879-83
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8706197-Adolescent,
pubmed-meshheading:8706197-Adult,
pubmed-meshheading:8706197-Aged,
pubmed-meshheading:8706197-Alfentanil,
pubmed-meshheading:8706197-Anesthesia,
pubmed-meshheading:8706197-Cholinesterase Inhibitors,
pubmed-meshheading:8706197-Dose-Response Relationship, Drug,
pubmed-meshheading:8706197-Edrophonium,
pubmed-meshheading:8706197-Enflurane,
pubmed-meshheading:8706197-Female,
pubmed-meshheading:8706197-Heart Rate,
pubmed-meshheading:8706197-Humans,
pubmed-meshheading:8706197-Isoquinolines,
pubmed-meshheading:8706197-Male,
pubmed-meshheading:8706197-Middle Aged,
pubmed-meshheading:8706197-Neuromuscular Junction,
pubmed-meshheading:8706197-Neuromuscular Nondepolarizing Agents,
pubmed-meshheading:8706197-Nitrous Oxide
|
pubmed:year |
1995
|
pubmed:articleTitle |
Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
|
pubmed:affiliation |
Department of Anaesthesia, Maisonneuve-Rosemont Hospital, University of Montreal, Quebec.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|